je.st
news
Tag: drug
Novartis launches first US 'biosimilar' drug at 15 percent discount
2015-09-03 23:44:28| Biotech - Topix.net
Novartis kicked off a new era in U.S. medicine on Thursday with the launch of the first "biosimilar" copy of a biotechnology drug approved in the United States, at a discount of 15 percent to the original. The Swiss drugmaker's generics unit Sandoz said Zarxio, its form of Amgen's white blood cell-boosting product Neupogen, would increase access to an important treatment by offering a "high-quality, more affordable version".
Tags: drug
percent
discount
launches
Experimental osteoporosis drug bests Lilly's Forteo in study
2015-09-02 18:26:08| Agriculture - Topix.net
Amgen Inc. and Belgian partner UCB SA said an experimental osteoporosis drug designed to promote new bone growth helped mend older women's hip bone density in an advanced clinical test, sending UCB's stock to the highest level in more than five years.
Tags: study
drug
experimental
osteoporosis
Experimental osteoporosis drug bests Lilly's Forteo in study
2015-09-02 16:00:07| Food - Topix.net
Amgen Inc. and Belgian partner UCB SA said an experimental osteoporosis drug designed to promote new bone growth helped mend older women's hip bone density in an advanced clinical test, sending UCB's stock to the highest level in more than five years.
Tags: study
drug
experimental
osteoporosis
Amgen's bone drug succeeds in late-stage study
2015-09-02 07:45:14| Biotech - Topix.net
Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study. Amgen's drug, romosozumab, met the main goal of showing a significant difference over Eli Lilly & Co's teriparatide in improving total hip bone density by the 12th month in postmenopausal women with osteoporosis.
Tags: study
drug
bone
succeeds
Alexion gets EU approval for drug acquired in Synageva deal
2015-09-02 03:25:24| Biotech - Topix.net
Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal, an enzyme-replacement therapy for an ultra-rare, life threatening disease. European health regulators approved Kanuma for patients with lysosomal acid lipase deficiency .
Sites : [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] next »